Avicanna Inc. (AVCNF)
OTCMKTS · Delayed Price · Currency is USD
0.1900
-0.0100 (-5.00%)
Oct 24, 2025, 9:37 AM EDT
Avicanna Market Cap
Avicanna has a market cap or net worth of $22.7 million as of October 24, 2025. Its market cap has decreased by -22.04% in one year.
Market Cap
22.70M
Enterprise Value
28.50M
Revenue
18.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.19
Market Cap Chart
Since July 18, 2019, Avicanna's market cap has decreased from 104.82M to 22.70M, a decrease of -78.35%. That is a compound annual growth rate of -21.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 22.70M | -2.86% |
| Dec 31, 2024 | 23.36M | -2.78% |
| Dec 29, 2023 | 24.03M | 5.84% |
| Dec 30, 2022 | 22.71M | -19.71% |
| Dec 31, 2021 | 28.28M | -26.61% |
| Dec 31, 2020 | 38.54M | -11.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 804.99M |
| Elite Pharmaceuticals | 644.08M |
| Glass House Brands | 608.71M |
| Silence Therapeutics | 340.08M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 327.41M |
| Northwest Biotherapeutics | 324.50M |
| American Oncology Network | 289.95M |